Fritextsökning
Innehållstyper
-
Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"
The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – ...
-
Donanemab godkänns i Storbritannien – men anses för dyrt för skattebetalarna
Eli Lillys alzheimerläkemedel donanemab godkänns i Storbritannien – men lär ändå inte bli tillgängligt för vanliga patienter. Orsaken är att behandlingen bedöms...
-
Extensive agreements signed at Scilifelab
Four agreements were signed between Swedish and Dutch life science players in connection with the Dutch state visit earlier this month.
-
Alzinova får FDA:s snabbspår för sitt alzheimervaccin
Biofarmabolaget Alzinovas vaccinkandidat mot Alzheimers sjukdom har beviljar Fast Track-status av USA:s läkemedelsmyndighet FDA.
-
Pfizer’s record year – topped the $100 billion mark
In 2022 Pfizer, as the first pharmaceutical company in history, reached an annual revenue of more than 100 billion dollars, thereby surpassing Johnson & Johnson...
-
Björn Arvidsson: Let's build on the positive momentum
Progress needs narratives and heroes, and more than ever, going into the new year feels like an opportunity for a fresh start.
-
The pandemic caused a reshuffle among the world’s vaccine giants – here is the new top list
Fuelled by the pandemic, the power balance in the global vaccine market has completely changed in recent years, a survey from Fierce Pharma shows
-
Newly discovered gene variant linked to protection against abdominal obesity
American researchers believe they have identified a rare gene mutation that protects against abdominal obesity and metabolic syndrome. The ambition is that the ...
-
Alert from the Swedish Medicines Agency: Many complications with gastric balloons
According to the Swedish Medicines Agency, an increasing number of serious complications are being reported in procedures with gastric balloons as a method for ...
-
Genes from Neanderthals can affect the correct drug dosage
A fifth of all Europeans carry gene variants inherited from Neanderthals, which cause certain drugs to break down more slowly. This may have implications for th...
-
Level up your medical expertise
Learn from innovative industry speakers from leading MedTech companies at ZEISS Quality Innovation Days.
-
Internationella vaccininstitutets kontor i Sverige växer
Internationella vaccininstitutets kontor i Stockholm har nu funnits i över ett år. Under året som gått har utbildningar och projekt dragits i gång, berättar Anh...
-
Event: Drug Development – Serendipity or Science
Drug development is a challenging journey, we will discuss questions you may not even consider asking. SDS and Medicon Village welcome you to an engaging afternoon.
-
Umeåinkubator startar internationellt program
Umeå Biotech Incubator, UBI, har varit med och utvecklat en rad framgångsrika svenska startuppbolag. Nu tar man ytterligare ett steg och drar igång ett internat...
-
Karolinska startar samarbete med läkemedelsföretag
Karolinska universitetssjukhuset har tecknat ett avtal med läkemedelsföretaget Bristol Myers Squibb för att starta ett samarbete kring cancerforskning.
-
RegSmart och Aleap startar samarbete
RegSmart Life Science har tecknat ett samarbetsavtal med Aleap, innovationshub för företag inom hälsa och Life Science i Oslo, Norge.
-
Göteborgsbolag får snabbspår i USA för IPF-behandling
Vicore Pharma har beviljats snabbspår i USA för sin läkemedelskandidat buloxibutid som utvecklas mot idiopatisk lungfibros, IPF.
-
Introduction of ZEISS Imaging Systems for Super-Resolution
Webinar recording about the ZEISS Lattice SIM technology.
-
Orexo avslutar partnerskap kring digital depressionsterapi
Det svenska läkemedelsbolaget Orexo har beslutat att inte satsa vidare på stödprogrammet vid depression, Deprexis, på den amerikanska marknaden. Avtalet med den...
-
ZEISS Metrology Shop provides planning security
ZEISS Metrology Shop brings it all together.
-
Promising Alzheimer’s study data sends Bioarctic stock soaring
The drug candidate lecanemab from Swedish company Bioarctic significantly slowed down the deterioration in patients with early on-set Alzheimer’s, according to ...
-
Marie Gårdmark: Potential step change – EU regulators get to play with data
A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approva...
-
Column: Repurposing as a golden ticket to approval
"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...
-
Webinar: What is Regulatory Affairs?
This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.
BREAKING